Muriel Tafflet

Muriel Tafflet

Auto-generated profile, based on publicly available information

Muriel Tafflet

Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), Paris, 75004, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
AEAhmed Elhakeem
Ahmed Elhakeem
ATAmy E Taylor
Amy E Taylor
HIHazel Inskip
Hazel Inskip
JHJon Y Huang
Jon Y Huang
TMToby Mansell
Toby Mansell
DLDeborah A Lawlor
Deborah A Lawlor
Aims: To examine associations of assisted reproductive technology (ART) conception (vs. natural conception: NC) with offspring cardiometabolic health outcomes and whether these differ with age. Methods and results: Differences in systolic (SBP) and diastolic blood pressure (DBP), heart rate (HR), lipids, and hyperglycaemic/insulin resistance markers were examined using multiple linear regression models in 14 population-based birth cohorts in Europe, Australia, and Singapore, and results were combined using meta-analysis. Change in cardiometabolic outcomes from 2 to 26 years was examined using trajectory modelling of four cohorts with repeated measures. 35 938 (654 ART) offspring were included in the meta-analysis. Mean age ranged from 13 months to 27.4 years but was <10 years in 11/14 cohorts. Meta-analysis found no statistical difference (ART minus NC) in SBP (−0.53 mmHg; 95% CI:−1.59 to 0.53), DBP (−0.24 mmHg; −0.83 to 0.35), or HR (0.02 beat/min; −0.91 to 0.94). Total cholesterol (2.59%; 0.10–5.07), HDL cholesterol (4.16%; 2.52–5.81), LDL cholesterol (4.95%; 0.47–9.43) were statistically significantly higher in ART-conceived vs. NC offspring. No statistical difference was seen for triglycerides (TG), glucose, insulin, and glycated haemoglobin. Long-term follow-up of 17 244 (244 ART) births identified statistically significant associations between ART and lower predicted SBP/DBP in childhood, and subtle trajectories to higher SBP and TG in young adulthood; however, most differences were not statistically significant. Conclusion: These findings of small and statistically non-significant differences in offspring cardiometabolic outcomes should reassure people receiving ART. Longer-term follow-up is warranted to investigate changes over adulthood in the risks of hypertension, dyslipidaemia, and preclinical and clinical cardiovascular disease.

15 August 2019 in Diabetes Care
Verified
Journal Article
Open access
PDF file
RCRachel E. Climie
Rachel E. Climie
TSThomas T. van Sloten
Thomas T. van Sloten
MPMarie-Cécile Périer
Marie-Cécile Périer
MTMuriel Tafflet
Muriel Tafflet
AFAurore Fayosse
Aurore Fayosse
JEJean-Philippe Empana
Jean-Philippe Empana
OBJECTIVE: Most previous studies on cardiovascular health (CVH) and incident type 2 diabetes (T2D) have used a single measure of CVH, and none have investigated the association with impaired fasting glucose (IFG). We examined the association between changes in CVH and incident T2D and IFG. RESEARCH DESIGN AND METHODS: Within the Whitehall II study, CVH was examined every 5 years from 1991/93 until 2015/16. Subjects with 0–2, 3–4, and 5–6 ideal metrics of CVH from the American Heart Association were categorized as having low, moderate, or high CVH, respectively. RESULTS: There were 6,234 participants (mean age 49.8 ± 6.0 years, 70% male) without prior cardiovascular disease and T2D, including 5,015 who were additionally free from IFG at baseline. Over a median follow-up of 24.8 (interquartile range 24.0–25.2) years, 895 and 1,703 incident cases of T2D and IFG occurred, respectively. Change in CVH between 1991/93 and 2002/04 was calculated among 4,464 participants free from CVD and T2D and among 2,795 participants additionally free from IFG. In multivariate analysis, compared with those with stable low CVH, risk of T2D was lower in those with initially high CVH (hazard ratio [HR] 0.21; 95% CI 0.09, 0.51), those who had persistently moderate CVH or changed from moderate to high CVH (moderate-moderate/high; HR 0.53; 95% CI 0.41, 0.69), low-moderate/high (HR 0.62; 95% CI 0.45, 0.86), and moderate-low (HR 0.74; 95% CI 0.56, 0.98). Results were similar for IFG, but the effect sizes were smaller. CONCLUSIONS: Compared with stable low CVH, other patterns of change in CVH were associated with lower risk of T2D and IFG.

16 November 2023 in Computers in Human Behavior
Verified
Journal Article
Closed access
SYShuai Yang
Shuai Yang
LPLorraine Poncet
Lorraine Poncet
MTMuriel Tafflet
Muriel Tafflet
SLSandrine Lioret
Sandrine Lioret
HPHugo Peyre
Hugo Peyre
JBJonathan Y Bernard
Jonathan Y Bernard

7 January 2025 in Paediatric and Perinatal Epidemiology
Verified
Journal Article
Open access
CDCourtney Dow
Courtney Dow
ELElsa Lorthe
Elsa Lorthe
JBJonathan Y Bernard
Jonathan Y Bernard
CGCédric Galera
Cédric Galera
LMLaetitia Marchand‐Martin
Laetitia Marchand‐Martin
BHBarbara Heude
Barbara Heude
Background: The relationship between maternal obesity and childhood cognitive development remains unclear. Prior studies did not adjust for important confounders, and preterm infants are a developmentally distinct group that remains scarcely examined.Objectives: To determine whether maternal prepregnancy body mass index (BMI) is associated with offspring intelligence quotient (IQ) up to 5 years and whether this relationship varies with gestational age.Methods: Data from two French birth cohorts, EDEN (all gestational ages) and EPIPAGE‐2 (preterm children born between 24 and 34 weeks of gestation), were used for this study. Maternal prepregnancy weight and height were used to calculate prepregnancy BMI. The Wechsler Preschool and Primary Scale of Intelligence was used to assess child IQ around 5 years. Multivariable models were adjusted for confounders, including socioeconomic status and paternal BMI.Results: Analytical cohorts included 1100 children from EDEN and 2629 from EPIPAGE‐2. Lower intellectual functioning (full‐scale IQ < 85) was observed in 8.1% of children in EDEN and 19.6% in EPIPAGE‐2. The prevalence of maternal obesity was 13.6% (EDEN) and 21.3% (EPIPAGE‐2) among children with lower intellectual functioning compared to 8.9% (EDEN) and 12.9% (EPIPAGE‐2) among children with normal intellectual functioning. Maternal prepregnancy obesity was associated with an approximately 3‐point decrease in full‐scale IQ scores in fully adjusted models (adjusted β −2.8, 95% confidence interval [CI] −5.6, −0.1 and −2.6, 95% CI −4.7, −0.6 in EDEN and EPIPAGE‐2, respectively). In EDEN, maternal obesity was associated with lower scores in the verbal IQ domain. Among infants born preterm (EPIPAGE‐2), maternal obesity was associated with lower scores in the processing, reasoning, and verbal IQ domains. Adjustment for paternal BMI did not change the magnitude of the relationship with maternal obesity.Conclusions: High maternal prepregnancy BMI is associated with child cognitive development around 5 years of age.

1 January 2025 in Depression and Anxiety
Verified
Journal Article
Open access
SASara Avendano
Sara Avendano
MTMuriel Tafflet
Muriel Tafflet
CGCedric Galéra
Cedric Galéra
LDLaetitia Davidovic
Laetitia Davidovic
BHBarbara Heude
Barbara Heude
JWJudith Van der Waerden
Judith Van der Waerden
Background: Adverse childhood experiences (ACEs) may negatively affect prenatal mental health. However, the use of a cumulative ACEs score may obscure the identification of which specific types of adversity are most strongly associated with unfavorable mental health outcomes. Aim: This study aims to evaluate the association between ACEs and prenatal symptoms of depression and anxiety using a cumulative score, a person‐centered approach, and the dimensional model of adversity and psychopathology (DMAP). Methods: Data were collected from 1887 pregnant women in the French Etude des Déterminants du développement et de la santé de l’ENfant (EDEN) cohort. To operationalize our exposure, we calculated a cumulative ACE score, threat and deprivation scores, and conducted latent class analysis (LCA). Depressive and anxious symptoms were assessed with the Center for Epidemiologic Studies‐Depression Scale (CES‐D) and the State‐Trait Anxiety Inventory state subscale (STAI‐S) questionnaires, using cutoffs of 16 and 38 indicating high symptoms. Participants were categorized into four outcome groups: (1) no symptoms, (2) high depressive symptoms only, (3) high anxious symptoms only, and (4) comorbid high symptoms. Multinomial regressions were performed. Results: LCA identified three ACE classes: low‐risk, family discordance, and multidimensional adversity. Women reporting two or more ACEs had higher odds of depressive and comorbid symptoms, compared to those with zero ACEs. Compared to the low‐risk class, women in the family discordance class had increased odds of high depressive symptoms (adjusted odds ratios [aOR] 95% confidence interval [CI] = 1.80 [1.33, 2.56]) and comorbid high symptoms (aOR [95% CI] = 2.04 [1.43, 2.89]). Threat experiences were significantly linked to high depressive symptoms (aOR [95% CI] = 1.48 [1.22, 1.79]) and comorbid high symptoms (aOR [95% CI] = 1.53 [1.25, 1.87]). Conclusion: Using the DMAP and LCA approaches, we found that ACEs related to the familial environment and relationships during childhood were most strongly associated with prenatal high depressive and comorbid symptoms. This highlights the importance of operationalizing ACEs beyond a cumulative score to better capture their role in the development of prenatal mental health difficulties.

7 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
BDBriana DeStaffan
Briana DeStaffan
PSPauline Scherdel
Pauline Scherdel
MTMuriel Tafflet
Muriel Tafflet
MCMarie-Aline Charles
Marie-Aline Charles
VTVassilis Tsatsaris
Vassilis Tsatsaris
WYWen Lun Yuan
Wen Lun Yuan
Background: Maternal blood pressure (BP) varies greatly during pregnancy in response to hemodynamic changes, which has led to debate surrounding the use of a single diagnostic threshold. Previous studies have generated “reference ranges” of BP in pregnancy, yet they lack implementation and translation to clinical practice. This study aimed to generate gestational age-specific references and analyze BP Z-scores to further explore cardiovascular dynamics in pregnancy and their potential clinical implications. Methods: Repeated measurements of BP from 2 to 44 gestational weeks were extracted from the obstetric files of 1,875 mothers from the French EDEN cohort. Percentiles of systolic (SBP), diastolic (DBP), and mean arterial pressure (MAP) were modeled using Generalized Additive Models for Location, Scale, and Shape (GAMLSS) as a function of gestational age. They were generated from a “low-risk” reference population defined by reduced cardiovascular risk factors and no hypertensive disorders. For each woman in the overall sample, Z-scores of BP were calculated relative to the “low-risk” percentiles, to assess how BP deviated from the expected trajectory across gestation. BP Z-score trajectories according to hypertensive disorders of pregnancy categories (chronic hypertension, gestational hypertension, and preeclampsia) were then plotted and compared. Results: A U-shaped trend was observed in overall and “low-risk” percentiles of SBP and MAP, with a nadir around 25 weeks and an increase in the last trimester. In the overall sample, SBP’s 95 th percentile curve remained below the 140mmHg diagnostic threshold between 15 and 35 weeks of gestation. The Z-score trajectories of women presenting with hypertensive disorders start to diverge as early as the first 5 gestational weeks, well-before their diagnoses (median age: 35-36 weeks). BP evolution differed according to type of hypertensive disorder, for example, a steep increase (>1 standard deviation) from early in pregnancy among preeclamptic women. Conclusion: This percentiles-to-Z-score approach can position individual risk of mothers while considering the natural variation of blood pressure across pregnancy. Our results question the applicability of a non-time-specific threshold to these dynamics. Beyond their potential clinical applications, these references can be used in further research to examine “abnormal” cardiovascular trajectories and their consequences for future maternal and offspring health.